Arif Kamal, MD, MBA, MHS, FACP, FAAHPM, is the physician quality and outcomes officer for the Duke Cancer Institute (DCI). He has dual appointments in the Division of Medical Oncology and Section of Palliative Care at Duke University. As a board-certified palliative medicine physician and medical oncologist, Dr. Kamal studies the link between delivery of high-quality palliative care and improved patient, caregiver and health system outcomes. He has research funding from the Agency for Healthcare Research and Quality (AHRQ), Cambia Health Foundation, and CMS Centers for Innovation to study the implementation of mobile health technologies in palliative and supportive care.

Dr. Kamal serves in several national capacities in the areas of healthcare quality and palliative care. He is the chair-elect for the American Society of Clinical Oncology (ASCO) Quality Committee and co-chairs the American Academy of Hospice and Palliative Medicine (AAHPM) e-Measures Workgroup. He is an active member of the American Society of Clinical Oncology (ASC) Supportive Care Advisory Group and Palliative Care Quality Measures Committee and AAHPM’s Quality Committee and Research Committee. He has also served on the AMA-PCPI Outcomes Task Force and Technical Expert Panels for the AAHPM Measuring What Matters Initiative and The Joint Commission’s Palliative Care Quality Measures project. He was recently appointed to the National Quality Forum Palliative and End-of-Life Care Standing Committee.

Dr. Kamal completed an internal medicine residency and hospice and palliative medicine fellowship at the Mayo Clinic – Rochester, Minnesota, and hematology/oncology fellowship at Duke University. He holds a master’s degree in health sciences in clinical research from the Duke Clinical Research Training Program and a master’s in business administration from the University of Massachusetts – Amherst.